MedTrace Logo

Clinical Response of Syrup Hydryllin® in Pakistani Subjects With Cough in Routine Practice

NCT05129761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2024-03-21

No results posted yet for this study

Summary

A cough is one of the most common medical complaints accounting for as many as 30 million clinical visits per year. It is the single most prevalent symptom on presentation to a physician's office. Up to 40% of these complaints result in a referral to a pulmonologist. Although, the cough is an essential defense mechanism, still, chronic cough may cause significant morbidity and substantially affect the quality of life and psychosocial wellbeing.

Conditions

Interventions

DRUG

Syrup Hydryllin

( Syrup Hydryllin \& Hydryllin Sugar-Free (Diphenhydramine, Ammonium Chloride, Menthol, Aminophylline) and Syrup Hydryllin DM (Dextromethorphan \& Diphenhydramine)

Sponsors & Collaborators

  • The Searle Company Limited Pakistan

    lead INDUSTRY

Principal Investigators

  • Syed Sarwar · The Searle Company Limited

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-28
Primary Completion
2023-06-01
Completion
2023-11-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05129761 on ClinicalTrials.gov